Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Name: Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection
Published: 2012
License: Public Domain

Gilead Sciences · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

treatment

chronic hepatitis c, hcv genotype 1 (gt-1), hcv genotype 4 (gt-4), hcv genotype 5 (gt-5), hcv genotype 6 (gt-6), hcv, sustained virologic response, direct acting antiviral, combination therapy, treatment-naïve, gs-7977, ribavirin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 843011
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.